Rosuvastatin

 On 1 June 2013 the PBS Schedule added the following item codes for rosuvastatin,
2574L 2584B 2590H 2594M 2606E 2609H 2628H 2636R
 

Restriction: For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs The Clinical criteria is: Patient must be receiving treatment under a GP Management Plan or Team Care Arrangements where Medicare benefits were or are payable for the preparation of the Plan or coordination of the Arrangements, AND the Clinical criteria is: The treatment must not be prescribed for hypercholesterolaemia if the patient has heterozygous familial hypercholesterolaemia.
These items contain the following brands:
APO-Rosuvastatin
Cavstat
Chem mart Rosuvastatin
Crestor
Rosuvastatin Actavis 10
Rosuvastatin GH 
Rosuvastatin RBX
Rosuvastatin Sandoz 
Terry White Chemists Rosuvastatin

These new items were added in addition to existing item codes:
3402C 3403D 3404E 3405F 9042X 9043Y 9044B 9045C
Restriction: For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs, and who are receiving treatment under a GP Management Plan or Team Care Arrangements where Medicare benefits were or are payable for the preparation of the Plan or coordination of the Arrangements
These items contained the following brands
Cavstat
Crestor
Rosuvastatin Actavis 10
Rosuvastatin GH 

These listings had the unintended consequence of denying eligible patients access to the brand of their choice.
To remedy this, the listings are being amended to the following, effective as of 1 June:

2574L 2584B 2590H 2594M 2606E 2609H 2628H 2636R
 

Restriction: For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs, and who are receiving treatment under a GP Management Plan or Team Care Arrangements where Medicare benefits were or are payable for the preparation of the Plan or coordination of the Arrangements
These items contained the following brands
Cavstat
Crestor
Rosuvastatin Actavis 10
Rosuvastatin GH 

3402C 3403D 3404E 3405F 9042X 9043Y 9044B 9045C
 

Restriction: For use in patients who meet the criteria set out in the General Statement for Lipid-Lowering Drugs The Clinical criteria is: Patient must be receiving treatment under a GP Management Plan or Team Care Arrangements where Medicare benefits were or are payable for the preparation of the Plan or coordination of the Arrangements, AND the Clinical criteria is: The treatment must not be prescribed for hypercholesterolaemia if the patient has heterozygous familial hypercholesterolaemia.

These items contain the following brands:
APO-Rosuvastatin
Cavstat
Chem mart Rosuvastatin
Crestor
Rosuvastatin Actavis 10
Rosuvastatin GH 
Rosuvastatin RBX
Rosuvastatin Sandoz 
Terry White Chemists Rosuvastatin

Importantly those patients who have been prescribed rosuvastatin for hypercholesterolaemia where they have heterozygous familial hypercholesterolaemia will still have access to rosuvastatin under the new item codes.